The use of radiosensitizing agents in the therapy of glioblastoma multiforme-a comprehensive review.

Strahlenther Onkol · 2022 · PMC9165247 · PMID 35503461

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

With median survival of 38 weeks for the experimental group and 31 weeks for the control group, statistical significance was not obtained [ 14 ], but showed a trend encouraging further evaluation.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.